[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.12.79. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,626
Citations 0
Viewpoint
Health Care Policy and Law
November 18, 2019

Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities

Author Affiliations
  • 1Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 2Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • 3Institutes for Behavior Resources Inc, REACH Health Services, Baltimore, Maryland
JAMA Intern Med. 2020;180(1):7-8. doi:10.1001/jamainternmed.2019.5731

People with opioid use disorder (OUD) frequently require prolonged hospital and skilled nursing facility care for complications of their drug use—including wounds, endocarditis, hepatitis, HIV/AIDS, and acute exacerbations of chronic diseases. In 2012, there were 500 000 hospitalizations related to OUD in the United States; in about 1 in 10 of these admissions, the patient was discharged to a skilled nursing facility.1 Current federal regulations, however, complicate the provision of effective treatment for OUD in hospitals and skilled nursing facilities. As a result, many patients experience costly cycles of complications, admission, discharge, repeated complications, and readmission with little gain to their health. In this Viewpoint, we argue that changing regulations of the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Drug Enforcement Administration (DEA) to align with evidence could expand access to care and save lives.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×